Immunohistochemistry in the evaluation of melanocytic tumors.
A review is given on the classification of melanoma-associated antigens and their relevance as tumor markers in tissue sections and cell preparation. Applications of immunohistochemistry in the diagnosis and prognosis of melanocytic tumors are discussed.
Ruiter
D J
DJ
Department of Pathology, University Hospital Nijmegen, Nijmegen, The Netherlands.
Bröcker
E B
EB
D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation / Q000032:analysis*; D000951:Antigens, Neoplasm / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D006023:Glycoproteins / Q000032:analysis; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D008545:Melanoma / Q000276:immunology* / Q000473:pathology / Q000556:secondary; D011509:Proteoglycans / Q000032:analysis; D009418:S100 Proteins / Q000032:analysis; D012680:Sensitivity and Specificity
D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D006023:Glycoproteins; D006684:HLA-DR Antigens; D011509:Proteoglycans; D009418:S100 Proteins; C069150:melanoma-associated proteoglycan antigen, human